{"id":"https://openalex.org/W4387948493","doi":"https://doi.org/10.1177/10600280231205023","title":"Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients","display_name":"Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients","publication_year":2023,"publication_date":"2023-10-26","ids":{"openalex":"https://openalex.org/W4387948493","doi":"https://doi.org/10.1177/10600280231205023","pmid":"https://pubmed.ncbi.nlm.nih.gov/37881915"},"language":"en","primary_location":{"id":"doi:10.1177/10600280231205023","doi":"https://doi.org/10.1177/10600280231205023","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10600280231205023","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093126829","display_name":"Daniel Tobben","orcid":"https://orcid.org/0009-0007-0498-7796","observed_orcids":["https://orcid.org/0009-0007-0498-7796"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Daniel Tobben","raw_affiliation_strings":["Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA"],"raw_orcid":"https://orcid.org/0009-0007-0498-7796","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113031244","display_name":"Sheniece Carpenter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sheniece Carpenter","raw_affiliation_strings":["Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050101203","display_name":"Rachel Kolar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Kolar","raw_affiliation_strings":["Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055677573","display_name":"Tyler Merritt","orcid":"https://orcid.org/0000-0002-6213-0324","observed_orcids":["https://orcid.org/0000-0002-6213-0324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tyler Merritt","raw_affiliation_strings":["Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022265261","display_name":"Tramaine Young","orcid":"https://orcid.org/0009-0008-6907-6296","observed_orcids":["https://orcid.org/0009-0008-6907-6296"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tramaine Young","raw_affiliation_strings":["Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA"],"raw_orcid":"https://orcid.org/0009-0008-6907-6296","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078864001","display_name":"Paloma Hauser","orcid":"https://orcid.org/0000-0001-7115-6633","observed_orcids":["https://orcid.org/0000-0001-7115-6633"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paloma Hauser","raw_affiliation_strings":["UNC Gillings School of Global Public Health, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Gillings School of Global Public Health, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022841353","display_name":"Tia E. Collier","orcid":"https://orcid.org/0000-0001-6252-8060","observed_orcids":["https://orcid.org/0000-0001-6252-8060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tia Collier","raw_affiliation_strings":["Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNC Health Rex, Raleigh, NC, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5093126829"],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.7246,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.68257745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"58","issue":"7","first_page":"678","last_page":"684"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-induced-constipation","display_name":"opioid-induced constipation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/naloxegol","display_name":"naloxegol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/methylnaltrexone","display_name":"methylnaltrexone","score":1.0},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.9409999847412109},{"id":"https://openalex.org/keywords/intensive-care-unit","display_name":"intensive care unit","score":0.9380000233650208},{"id":"https://openalex.org/keywords/parenteral-opioids","display_name":"parenteral opioids","score":0.6700000166893005},{"id":"https://openalex.org/keywords/time-to-first-bowel-movement","display_name":"time to first bowel movement","score":0.8899999856948853},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9319999814033508},{"id":"https://openalex.org/keywords/stool-frequency","display_name":"stool frequency","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C2991859549","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critically ill","level":2,"score":0.7778725028038025},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.74666428565979},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5872440338134766},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4884149432182312},{"id":"https://openalex.org/C2781112942","wikidata":"https://www.wikidata.org/wiki/Q178436","display_name":"Constipation","level":2,"score":0.45209720730781555},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.395926296710968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1492498517036438},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000079689","descriptor_name":"Opioid-Induced Constipation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000644","descriptor_name":"Quaternary Ammonium Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000644","descriptor_name":"Quaternary Ammonium Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003248","descriptor_name":"Constipation","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003248","descriptor_name":"Constipation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007362","descriptor_name":"Intensive Care Units","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007902","descriptor_name":"Length of Stay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009019","descriptor_name":"Morphinans","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009019","descriptor_name":"Morphinans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016638","descriptor_name":"Critical Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/10600280231205023","doi":"https://doi.org/10.1177/10600280231205023","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10600280231205023","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:37881915","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37881915","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1996075855","https://openalex.org/W2004303723","https://openalex.org/W2103154281","https://openalex.org/W2104710488","https://openalex.org/W2164448950","https://openalex.org/W2402418945","https://openalex.org/W2556644374","https://openalex.org/W2908912525","https://openalex.org/W2944732755","https://openalex.org/W4310153937"],"related_works":["https://openalex.org/W4389730232","https://openalex.org/W4307774722","https://openalex.org/W2556644374","https://openalex.org/W7219921138","https://openalex.org/W4310153937","https://openalex.org/W4389730279","https://openalex.org/W3005040067","https://openalex.org/W2138520181","https://openalex.org/W2058964422","https://openalex.org/W3004235380"],"abstract_inverted_index":{"BACKGROUND:":[0],"Constipation":[1],"impacts":[2],"58%":[3],"to":[4,39,72,108,141,213,217],"83%":[5],"of":[6,23,35,43,54,99,114,123,169],"critically":[7,59,231],"ill":[8,60,232],"patients":[9,70],"and":[10,20,86,134,149,161,165,178,193,197,208,221],"is":[11],"associated":[12],"with":[13,224],"increased":[14,21],"time":[15,107,140,212],"on":[16,68],"mechanical":[17],"ventilation,":[18],"delirium,":[19],"length":[22],"stay":[24],"(LOS)":[25],"in":[26,58,171,227,230],"the":[27,41,52,73,93,97,112,166,187],"intensive":[28],"care":[29],"unit":[30],"(ICU).":[31],"OBJECTIVE:":[32],"The":[33,103],"purpose":[34],"this":[36],"study":[37,204],"was":[38,66,106,144,157,174,195],"evaluate":[40],"efficacy":[42],"enteral":[44],"naloxegol":[45],"(NGL)":[46,160],"versus":[47],"subcutaneous":[48],"methylnaltrexone":[49],"(MNTX)":[50],"for":[51,81,147,152,176,180,191],"management":[53],"opioid-induced":[55],"constipation":[56],"(OIC)":[57],"patients.":[61,154,233],"METHODS:":[62],"A":[63],"retrospective":[64],"analysis":[65],"conducted":[67],"adult":[69],"admitted":[71],"ICU":[74,132],"who":[75],"received":[76],"a":[77,219],"parenteral":[78],"opioid":[79],"infusion":[80],"at":[82],"least":[83],"4":[84],"hours":[85,126,146,151,173],"experienced":[87],"no":[88],"bowel":[89],"movement":[90],"(BM)":[91],"within":[92],"48-hour":[94],"period":[95],"preceding":[96],"administration":[98],"NGL":[100,115,128,148,177,192,207,215],"or":[101,116,129],"MNTX.":[102,181],"primary":[104],"outcome":[105],"first":[109,142],"BM":[110,143,190],"from":[111],"start":[113],"MNTX":[117,130,153,194,209],"therapy.":[118],"Secondary":[119],"outcomes":[120],"included":[121],"number":[122,168],"BMs":[124,170],"72":[125,172],"following":[127],"administration,":[131],"LOS,":[133],"cost-effectiveness.":[135],"RESULTS:":[136],"=":[137],"0.047).":[138],"Median":[139,155],"23.7":[145],"18.3":[150],"LOS":[156],"14":[158],"days":[159,163],"12":[162],"(MNTX),":[164],"average":[167],"3.9":[175],"3.8":[179],"Using":[182],"wholesale":[183],"acquisition":[184],"cost":[185,188],"(WAC),":[186],"per":[189],"$21.74":[196],"$170.00,":[198],"respectively.":[199],"CONCLUSION":[200],"AND":[201],"RELEVANCE:":[202],"This":[203],"determined":[205],"that":[206],"had":[210],"similar":[211],"BM.":[214],"appears":[216],"be":[218],"safe":[220],"effective":[222],"alternative":[223],"cost-saving":[225],"potential":[226],"treating":[228],"OIC":[229]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-10-27T00:00:00"}